Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L Vallance

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Pediatric Hematology/Oncology|August 1, 2023
Intracranial Relapse in Pediatric SarcomaDanielle E Smith, Tyler Hamby, Kenneth Heym, et al.
Genetics in Medicine Open|December 13, 2024
Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicityOwen R Hirschi, Stephanie A Felker, Surya P Rednam, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for PathogenicityOwen R Hirschi, Stephanie A Felker, Surya P Rednam, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Renal tumorsJames I Geller, Andrew L Hong, Kelly L Vallance, et al.
Pediatric Blood & Cancer|November 3, 2022
Pediatric renal tumor epidemiology: Global perspectives, progress, and challengesJaime Libes, Janna Hol, Joaquim Caetano de Aguirre Neto, et al.
Pediatric Blood & Cancer|April 25, 2023
Pediatric renal tumor epidemiology: Global perspectives, progress, and challengesJaime Libes, Janna Hol, Joaquim Caetano de Aguirre Neto, et al.
Cancer|April 9, 2020
Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2Lauren N Parsons, Elizabeth A Mullen, James I Geller, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Annals of Surgery|April 11, 2025
Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2Lindsay A Renfro, Kelly L Vallance, Ian C Tfirn, et al.
Med (New York, N.Y.)|October 4, 2022
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumorsDiego F Coutinho, Prabhjot S Mundi, Lianna J Marks, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pediatric Hematology/Oncology|August 1, 2023
Intracranial Relapse in Pediatric SarcomaDanielle E Smith, Tyler Hamby, Kenneth Heym, et al.
Genetics in Medicine Open|December 13, 2024
Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicityOwen R Hirschi, Stephanie A Felker, Surya P Rednam, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for PathogenicityOwen R Hirschi, Stephanie A Felker, Surya P Rednam, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Renal tumorsJames I Geller, Andrew L Hong, Kelly L Vallance, et al.
Pediatric Blood & Cancer|November 3, 2022
Pediatric renal tumor epidemiology: Global perspectives, progress, and challengesJaime Libes, Janna Hol, Joaquim Caetano de Aguirre Neto, et al.
Pediatric Blood & Cancer|April 25, 2023
Pediatric renal tumor epidemiology: Global perspectives, progress, and challengesJaime Libes, Janna Hol, Joaquim Caetano de Aguirre Neto, et al.
Cancer|April 9, 2020
Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2Lauren N Parsons, Elizabeth A Mullen, James I Geller, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Annals of Surgery|April 11, 2025
Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2Lindsay A Renfro, Kelly L Vallance, Ian C Tfirn, et al.
Med (New York, N.Y.)|October 4, 2022
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumorsDiego F Coutinho, Prabhjot S Mundi, Lianna J Marks, et al.
Pageof 2